2016

The Department of Justice ("DOJ") recently entered into a settlement of a quit tam lawsuit against Pfizer, Inc. and…

This article examines an apparent breakdown in corporate culture that goes beyond the subsidiaries to the parent…

The IMS Institute for Healthcare Informatics released its annual Medicines Use and Spending in the U.S. report.…

Corporate Integrity Agreements are thought to set the standard for compliance programs, but when viewed against the norms…

The Centers for Medicare and Medicaid Services (CMS) released its proposed 962 page rule for the Medicare Access and…

Prescription drugs have been in the news for months: pricing issues, transparency problems, and the presidential…

activities In this article, we review advice from industry thought leaders on (1) how to ensure compliance officers are a part of…

In a recent securities filing, Novartis alluded to future issues for the Swiss company. In their Interim Financial…

2016 has gotten off to a pretty good start for Polaris. In mid-April, the company finalized its third major deal of…

Readers who attended CBI's Annual Pharmaceutical Compliance Congress last year may have seen Securities and Exchange Commission…